Glycemic Control of Non-Hodgkin Lymphoma (NHL) Non-Diabetes Mellitus (DM) Patient in the First CHOP Chemotherapy
Sign Up to like & getrecommendations! Published in 2021 at "Medico-Legal Update"
DOI: 10.37506/mlu.v21i1.2341
Abstract: Non-Hodgkin’s lymphoma (NHL) chemotherapy is cyclophosphamide, doxorubicin, vincristine, andprednisone (CHOP) have hyperglycemia side effects that affect the success of chemotherapy. Improvedglycemic control decreases morbidity and mortality. Determine the glycemic control changes in non-DMNHL patients before… read more here.
Keywords: chemotherapy; non hodgkin; first chop; chop chemotherapy ... See more keywords